The Patent Finder

Compositions and Methods for Treating Central Nervous System Disorders

Lipocine Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 17/823,080, filed Aug 29, 2022. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,337,987Compositions and Methods for Treating Central Nervous System Disorders
In force
 · High confidence
Lipocine Inc.In force
High confidence
US 11,478,485Compositions and Methods for Treating CNS Disorders
In force
 · Medium confidence
Lipocine, Inc.In force
Medium confidence
US 12,208,103Compositions and Methods for Treating CNS Disorders
In force
 · Medium confidence
Lipocine Inc.In force
Medium confidence
US 12,527,805Compositions and Methods for Treating CNS Disorders
In force
 · Medium confidence
Lipocine, Inc.In force
Medium confidence
US 11,969,434Oral Allopregnanolone Compositions and Methods of Use
In force
 · High confidence
Lipocine, Inc.In force
High confidence
US 12,186,327Oral Allopregnanolone Compositions and Methods of Use
In force
 · Low confidence
Lipocine Inc.In force
Low confidence
US 12,409,185Oral Allopregnanolone Compositions and Methods of Use
In force
 · Low confidence
Lipocine, Inc.In force
Low confidence
US 12,714,7173Alpha-OH-5Beta-Pregnan-20-One Compositions and Methods for Treating Central Nervous System Disorders
In force
 · Medium confidence
Lipocine, Inc.In force
Medium confidence
Application 17/723,2033Alpha-OH-5Alpha-Pregnan-20-One Compositions and Methods for Treating CNS Disorders
Pending
Not granted
Lipocine, Inc.PendingNot granted
Application 17/929,895Compositions and Methods for Treating CNS Disorders
Abandoned
Abandoned May 15, 2026
Lipocine Inc.AbandonedAbandoned May 15, 2026
3 more patents in this group · Pro
10 of 13 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 13.
Upgrade to Pro
8 of these are in force and held by Lipocine Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited